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Early in the morning of 16 April 2014, my father, Douglas L.
Coleman, died at his home in Maine, surrounded by family
and friends. The cause of death was an erosive basal cell
carcinoma that slowly, but inexorably, penetrated his face.
Dad was born in Stratford, Ontario, in 1931, an only child
of impoverished parents. His family lived on cottontail rab-
bits, squirrels and the odd fish, mostly pike, supplemented
with garden vegetables. Breakfast cereal was eaten dry, except
on Sundays when he could have milk. Dad was the first
Coleman to finish high school and he attended college at
McMaster University in Hamilton, Ontario. It was at
McMaster he met the love of his life and future wife, Beverly
Benallick, the only female chemistry major. Dad attended
graduate school at the University of Wisconsin in Madison
where he pursued his interest in biochemistry in the laboratory
of Professor Carl Baumann. When he received his PhD in
1958, the work prospects in Canada were not promising and
he accepted a position at The Jackson Laboratory in Bar
Harbor, Maine, where he spent his entire career.
In the 1960s, Dad became interested in two strains of obese
mice that arose out of The Jackson Laboratory breeding
stocks: ob/ob and db/db. While both of these mice strains
are always hungry (hyperphagia) and consequently massively
obese, the ob and db mutations are located on different chro-
mosomes [1, 2]. Early experiments established that the diabe-
tes resulted from a problem in the utilisation of insulin [3] and
that the genetic background could have a profound effect on
the severity of the disease [4]. Dad wondered whether some
circulating factor might control the obesity. If such a hypo-
thetical factor was present in the blood, he reasoned that he
could test for its presence by linking the blood supplies of the
animals. One such means to link blood supplies involved
surgically joining two mice by skin-to-skin anastomosis—a
technique termed parabiosis.
Dad’s parabiotic pairings were not only elegant but also led
to the heretical conclusion that genetics could control obesity.
In a control experiment, linking the blood supply of two normal
mice, the pairs remained active and healthy for the duration of
the experiment. In contrast, pairing ob/ob with normal mice
caused the ob/ob mice to reduce their food intake to that
observed in the normal–normal pairing [5]. The ob/ob mice,
therefore, lost weight but survived for the duration of the
experiment. This result suggested that the normal mice pro-
duce a blood-borne ‘satiety factor’ that could control obesity
and that the ob/ob mice recognised and responded to this
satiety factor.
Parabiotic pairings with the db/db mice were even more
fascinating.When paired with normal mice, the db/db partners
continued to gain weight, while the normal mice in each pair
consistently died [6]. At necropsy, the normal mice lacked any
food in their stomachs and had no glycogen in their livers:
they had starved to death. Based on these results, Dad con-
cluded that the db/db mice not only produced a blood-borne
satiety factor powerful enough to starve a normal mouse but,
in addition, were not responsive to this satiety factor
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themselves. The parabiotic pairing between db/db and ob/ob
mice rounded out the analysis [5]. As before, the db/db pairs
continued eating and gaining weight. In contrast, ob/ob pairs
stopped eating, their blood sugar levels declined and they
ultimately starved to death, albeit over a longer timeframe
than the normal mice in a db/db–normal pair, due to a much
more substantial adipose tissue reservoir in the ob/ob mice.
Thus, the ob/ob mice, like the normal mice, responded to the
factor provided by the db/db mice.
Taken together, the parabiosis experiments clearly indicat-
ed that the ob/ob mutant could respond to, but could not
produce, a blood-borne satiety factor, while the db/db mutant
overproduced a blood-borne satiety factor, but could not re-
spond to it—perhaps owing to a lack of the necessary receptor.
With the notable exception of receiving the Claude Bernard
Award from the European Diabetes Federation in 1977 [7],
these discoveries were largely dismissed at the time. Many in
the obesity field favoured the leading thinking of the day: that
mice (or people) are overweight because they overeat
(behaviour) not because of a genetic predisposition (physiol-
ogy). Although Dad correctly predicted that adipose tissue
produced the factor, he was not able to identify the satiety
factor as he focused his attention on isolating the wrong
components (fatty acids and lipid extracts). Similarly, ventro-
medial nucleus lesions in db/db mice suggested that the pri-
mary defect in the db/dbmice resided in the hypothalamus [8],
but the satiety factor receptor would not be identified until
decades later. In 1994, Dr Jeffrey Friedman and co-workers
identified the satiety factor as a hormone, which they named
leptin [9]. With the subsequent cloning of the leptin receptor
[10] and the identification of the mutant receptor in the db/db
mouse [11, 12], many predictions made based on the parabi-
osis experiments were proven: adipose tissue produced a
satiety factor (leptin) that functions in a feedback loop to
regulate appetite. The ob/ob mice lacked functional leptin
but could respond to it; the db/dbmice lacked functional leptin
receptors and overproduced leptin in a futile effort to control
their hunger. Dad was elected to the National Academy of
Sciences in 1998 and received the Gairdner Foundation Inter-
national Award (2005), the Shaw Prize (2009), the Albert
Lasker Award for Basic Medical Research (2010), the King
Faisal International Prize for Medicine (2013) and the BBVA
Foundation Frontiers of Knowledge Award (2013).
Dad always felt that his career as a biochemist spanned the
heyday of basic science. The NIH funding rate was >40%;
The Jackson Laboratory charged 5% overheads. He enjoyed
working independently to an extent that would be nearly
impossible for a laboratory head to achieve today. His labora-
tory consisted primarily of himself and a single high school-
educated technician that he employed for nearly three de-
cades. Although he mentored one or two high school students
each summer, he had only one graduate student and very few
postdoctoral fellows during his career. I had never examined
Dad’s curriculum vitae until I hosted him as a speaker at the
Feinstein Institute forMedical Research (Manhasset, NY,USA)
in 2009.When I did so, I was struck by the fact that a quarter of
his publications were authored by only himself and the vast
majority were authored by three or fewer researchers. Dad also
felt that the public, through the NIH, paid for his research. As
such, he believed that the public owned his discoveries and,
therefore, like many scientists of his generation, he had mixed
feelings about patenting scientific discoveries for personal gain.
Indeed, partly motivated through this line of thinking, Dad
donated all of his scientific prize money to various charities.
Faced with a changing research culture, Dad retired early in
1993. Unlike many emeritus scientists, he made a clean break,
only returning to The Jackson Laboratory to use the fitness
centre. To my delight, he entered retirement with great enthu-
siasm and spent his final years travelling and working on the
town planning board as well as with forestry and conservation
groups. While he will be remembered as a pioneer in demon-
strating a genetic cause of obesity, he was very proud of the
thousands of acres of Maine coastline and wetlands that he
helped preserve for future generations.
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